JRPGfan said:
Thats old news isnt it? |
Yes, it's kind of old news but Reuters loves their Covid doom, so there you go.
As for those numbers, that was just the press theorizing. We don't have numbers from actual trials, just controlled in vitro studies.
For all we know, it could be a big drop comparable to Novavax's, where its efficacy dropped from 95% in conditions similar to Pfizer's phase III trials down to 50% - 60% with the South African variant. Or it could be a smaller drop of about one-fifth like it happened with J&J's single-dose vaccine.
Of course, like every expert has been trying to hammer in the minds of efficacy junkies, it's far, far easier to prevent severe disease than infection. And that all the vaccines should continue doing that very well.
Last edited by haxxiy - on 19 February 2021